Compare DraftKings Inc (DKNG) vs Figs Inc (FIGS) Price & Performance

DraftKings (DKNG) trades at $19.15, down 3.04% on the day and near its 52-week low of $18.95, reflecting bearish technical momentum. Fundamentally, revenue grew to $6.05 billion in 2025 with a slight net profit of $3.71 million, but recent quarterly EPS misses and a negative net income margin of -2.68% for 2026 highlight profitability challenges. The stock's high P/E of 246.33 signals premium valuation despite operational improvements, including positive operating cash flow of $662.86 million in 2025.

The outlook is mixed: strong analyst consensus (75% buy ratings) and a $33.13 price target suggest upside potential from sportsbook growth and prediction market expansion, but risks include competitive pressures, regulatory uncertainty from Brazil's betting ban, and volatility from high valuation multiples. Investors face a trade-off between long-term growth prospects and near-term earnings instability.

FIGS trades at $14.06, down 0.28% today, with a bullish technical signal from moving averages. The company shows strong revenue growth from $556M in 2024 to $631M in 2025, with net income surging to $34M. Recent quarters have consistently beaten EPS expectations, and international sales grew 67% in Q2 2026. Analyst consensus is bullish with a $18.00 price target suggesting 28% upside potential from current levels.

The outlook remains positive with accelerating growth and margin expansion, though the stock's rich valuation (P/E 42.6) presents risk if execution falters. Key catalysts include continued international expansion and sustained demand from healthcare professionals, while risks include premium valuation pressure and competitive threats in medical apparel.